CLARIS LIFESCIENCE LTD. Important point to be included in hr project >no of employees ... >no of share capital.... >hr planning.... >recuritment selection polices* >source of recruitment.... >method of selection... >oraiontation programme... >remunaration to employess* >all the componants* salary ,wages,incentives,benifits ,persive sites* >performance of present system* >promotion, transfer... >industrial relation & trade union... >hr audit* >hr department... ABOUT THE OUR RECERCH IN CLARIS Arjun handa Managing director & ceo Bharat shah h.r .vise manager company name where it.. us uk bankok product provive pna tna
Transcript
CLARIS LIFESCIENCE LTD.
Important point to be included in hr project >no of employees ...>no of share capital....>hr planning....>recuritment selection polices*
>source of recruitment....>method of selection...>oraiontation programme...>remunaration to employess*>all the componants* salary ,wages,incentives,benifits ,persive sites*>performance of present system*>promotion, transfer...>industrial relation & trade union...>hr audit*>hr department...
Mba institute of claris devlop info.....Feedback ,containt, sip(sumar internship project)
Xcellon intitute
Mba +pgp in give inCash knowlege
Vision for money + serve a better services for societyPgp playgroup
Ahmedabad
Redrict juniorsundaronegulbytekara
7 to also
Gujarat uni. Apporove
LivererntClaris Quality,vision, mission
Claris info......Iv 60 sec to go medicine to human bodyQuality componinanceFor hr manager say to student about her ersonal openion
ObsarvationReadTrelavante
Experiance
ANCHOR NAME BIRJU PRAQTIK
CLARIIS PRODUCTCLARIS STATALION GLASS BOTTEL WASH THAT
Mbbs attribute background
Background>asrra gencala > sum farma > industriesGeta >hrm >management>Human decision>SOCIETY
79 countryBrazilUsUk
Safety paant
>one plaNT, manufacring plant, glass palnt
India in one palntCampus
Hr vise manager openion about tyhe hoe the he management about to take info,..... ApprisalKey skill area Role effecivenessPrd performance reduce drec..
360* degree 1 year continuess process
Employees training Internal extarnal all3000 workers5000 employees
Power clean energey agescieanceFoods
Inabueses area..Inteebtes area..
About us
Claris Lifesciences is one of the largest sterile injectables pharmaceutical companies in India with a market presence in 76 countries worldwide. We primarily manufacture and market products across multiple markets, and therapeutic segments. A significant majority of these products are generic drugs that are capable of being directly injected into the human body and are predominantly used in the treatment of critical illnesses.
Our products range across various therapeutic segments, including anaesthesia, critical care, anti-infectives, renal care, infusion therapy, enteral & parenteral nutrition and oncology. We offer injectables in various delivery systems, such as glass and plastic bottles, vials, ampoules, pre-filled syringes and non-PVC/PVC bags.
Our customer base primarily includes government and private hospitals, aid agencies, and nursing homes.
We have five manufacturing facilities spread over a 78-acre campus located in Ahmedabad,India. Certain of these facilities have been approved by foreign regulatory authorities including the USFDA, MHRA (UK), TGA (Australia), NAM (Finland), GCC FDCA (Gulf Co-operation Council including Saudi Arabia, U.A.E. and other countries in the Middle East), ANVISA (Brazil) and INVIMA (Colombia). Our manufacturing capabilities have received several awards from prestigious institutions like IDMA (Indian Drug Manufacturers' Association) and Frost & Sullivan.
Our capabilities and experience span across all business verticals in the generic injectables industry. We have a trained workforce across business functions, such as R&D for product development, regulatory affairs for obtaining product registrations, manufacturing, and sales and marketing.
Message from CEO
Welcome to the world of Claris Lifesciences Limited, an Indian sterile injectables pharmaceutical company having presence in 76 countries worldwide. It gives us immense pleasure that you have taken time to get an insight about Claris.
Today, world's pharmaceutical industry is growing by leaps and bounds; and India is showing the most promising signs in this industry with generics constituting a significant portion of the Indian Pharmaceutical Industry.
The Indian generics businesses which were earlier considered as a parasite, is now grabbing attention & respect from all major leading pharmaceutical companies across the world. With the shift in paradigm, the MNCs are now eying to collaborate with Indian generics players. Claris has made a niche in this generics sector through its sterile Injectable products ranging across therapies and markets.
Claris is consistently working towards its vision of becoming a leading sterile injectables company of the world, keeping alive the ultimate motto of saving the Earth's most precious resource – Human Lives. Claris has surpassed significant milestones in short period of time in the areas of technology development, research, regulatory approvals, manufacturing & supply chain excellence and organizational culture as a whole. Certain of our manufacturing facilities have been approved by various regulatory authorities including USFDA, MHRA (UK) and TGA (Australia). The facilities are ISO 9001-2000 and WHO GMP certified. The company has been recognized for its quality and processes and has won several prestigious Indian Drug Manufacturers' Association Awards as well as India Manufacturing Excellence Awards. We attribute our success to continued patronage of our valued customers and partners, who stood by us over the years and who have put in their trust in us. On the other hand, our internal driving force of dedicated & specialized team members including scientists and professional, who are working above and beyond the call of duty to drive Claris to next level, are certainly on an equal plane. We are sure our unique business model, work practices, and culture of quality & excellence in everything we do will lead our relationships with stakeholders to a newer height, and ultimately will pave our way to a new growth trajectory and horizon of success.
Arjun Handa.VisionTo be one of the worlds’ leading and most admired pharmaceutical companies in the global Generics industry.
To continually create value and bring pride to our stakeholders, partners, customers and the community at large.
To preserve earth’s most precious resource… human lives.
MissionA world-class organization, built on,
Overview Certifications/Recognitions
• Unique Business Model
•Therapy focus with hospital as customer
• Range of Specialty Products – one of few manufacturers
• Accepted by international regulatory authorities including USFDA, MHRA (UK), TGA (Australia), NAM (National Agency for Medicine) Finland, GCC (Gulf Co-operation
worldwide
•World-class Manufacturing facilities
• International quality standards and certifications
•Large scale manufacturing capacities
•Enjoying significant cost advantage
• Product development and regulatory capabilities
• Global Brands
• Market Leadership
•Extensive Sales & Distribution (S&D) Network
• Highly respected amongst the medical fraternity
Council), ANVISA (Agencia Nacional de Vigilancia Sanitaria) Brazil, INVIMA (Instituto Nacional de Vigilancia de Medicamentos Y Alimentos) Colombia, to name a few
• India Manufacturing Excellence Awards from The Economic Times and Frost & Sullivan for 3 consecutive years viz. 2007, 2008 and 2009.
• IDMA Quality Excellence Award for 4 years.
•Certified for WHO GMP and ISO 9001:2000
Businesses
Therapies Market Presence
• Anesthesia
•Plasma Volume Expanders & Blood Products
• Clinical Nutrition
• Renal and Transplant
• Oncology
• Anti infectives
• Infusion therapy
• Presence in 76 countries across Latin America, Europe, Gulf, Africa, CIS, Central Asia and Asia- Pacific
• Form-Fill-Seal (FFS) technology for Non-PVC bags
•Blow-Fill-Seal (BFS) technology for plastic bottles
Quality
“Would we use it our on dearest ones?”
If the answer is an unhesitant “Yes”, the product has passed our final quality test.
We call this “Emotional Pharmacopoeia.”
Regulatory
• Trained and committed manpower for regulatory filing across the globe.
• Sound and complete understanding of International Regulatory Requirements
• Successfully attained key international regulatory approvals including USFDA, MHRA(UK), TGA (Australia), NAM (National Agency for Medicine) Finland, GCC (Gulf Co-operation Council), ANVISA (Agencia Nacional de Vigilancia Sanitaria) Brazil, INVIMA (Instituto Nacional de Vigilancia de Medicamentos Y Alimentos), Columbia to name a few
• Obtained over 1,100 product registrations, including 25 ANDAs.
Product Development
• New Products
Formulation Development
In licensing
Toll Manufacturing
• NDDS development ( eg: PNA™)
• New Drug Delivery Systems
Multichamber Bags
PEGylated Liposomal Technology
• Development of API with DMF source for captive consumption
• Speciality Kilolab APIs.
• Full fledged center with advanced equipment and experienced scientific personnel
Company Evolution
1999
Inauguration of first international office in Brazil. Clarion I, the first manufacturing facility with 3 production line
2002
Received the WHO GMP certificate for our Clarion I manufacturing facilityReached Rs. 1 billion mark in sales turnover
2003
Manufacturing facility approved by INVIMA, Colombia and ANVISA, Brazil
2004
Commercial production started at Clarion II manufacturing facility
2005
Clarion I manufacturing facility approved by the MHRA, UKReceived first product registration from MHRA, UK.The Company received its first regulated market order from the Netherlands.Filed 6 ANDAs with the USFDA.
2006
First Carlyle Ventures III invested Rs. 905.04 million in Equity Shares and convertible preference shares in our Company.
Top 2007
The USFDA granted approval of our Company’s sterile injectable manufacturing facility in Clarion I.Received Gold Award in India Manufacturing Excellence Awards from Frost & Sullivan Received Gujarat Logistics Award
2008
Received approval for 4 ANDAs in the USACommenced own sales and marketing activities in the USA. Launch of a range of infusion products in non-PVC bags in India.Received Gold Award in India Manufacturing Excellence Awards from Frost & SullivanReceived Indian Drug Manufacturers' Association Quality Excellence Award
2009
One of our Company’s non-resident Subsidiaries entered into a business arrangement with Pfizer Asia Contract Operations Pte. Ltd. for the marketing and supply of specific sterile injectables in certain regulated markets. Received Gold Award in India Manufacturing Excellence Awards from Frost
& SullivanReceived Indian Drug Manufacturers' Association Quality Excellence Award
2010
Received a letter from the USFDA in relation to the registration of our aseptic manufacturing line. Launched IPO and listed securities on BSE
India
Having established its presence in India in 1999, Claris continues to grow from strength to strength with every passing year.
Claris enjoys market leadership across several products and categories in India including Propofol, Parenteral Nutrition and Infusions. The company continuously endeavors to support upgrade of medical care in the country with the introduction of breakthrough new products and technologies. It has several firsts to its credit including
• The revolutionary new anesthetic propofol under brand name Profol™
• Oral glutamine under brand name Glutammune™
• Triple chamber CAPD system Trisafe™
• Triple chamber nutrition system with parenteral route administration – TNA Peri™
Claris’ customer base in India includes institutions, large corporate hospitals and nursing homes. In line with its commitment to the cause of critical care in the country, Claris remains at the forefront of efforts towards medical education including participation in several national and international congresses, supporting of training programs for young doctors, publication of scientific journals and other such initiatives.
InternationalEver since its inception, Claris has focused not only in developing its domestic market, but also overseas markets as well. So much so, almost 50% or more of Claris’ revenue is generated from the international markets, through a sales and distribution network spread across many countries.
Critical success factors for manufacturing and marketing pharmaceutical products for international markets are: 1.Regulatory Approvals of the manufacturing unit2.Registration of Product 3.Established Sales & Distribution network
International Market Coverage:Our International business division markets products across various therapies worldwide that can be categorized across 3 main businesses for Claris:
1.Critical Care: Therapies include Anesthesia, Clinical Nutrition, Plasma Volume Expanders & Blood Products2.Renal & Oncology: Peritoneal Dialyses, Transplant Medicine, Chemotherapeutic agents and Oncology & Renal support care products. 3.Hospital Care: This division markets hospital products like Common Infusion solutions, Electrolytes and Anti infectives
1. Emerging Markets: • Asia • Latin America • Africa • Middle East • CIS2. Developed markets: USA, EU, Nordic, Australasian and Far East markets. Claris’ long term growth and increased profitability in operations will continue with the year on year increasing contribution from these developed or regulated markets.
Claris over the years has been able to setup a huge proprietary sales and distribution network and has set up subsidiaries and offices across major markets. These offices along with the corporate head quarters in India play an important role in managing international operations efficiently.
Claris image and branding have been established through regular and award winning participation in International Pharma Business and Medical Conferences, CMEs, and other CRM activities.
For Claris, International business has always remained an area of successful strategic business growth, and will remain so in the years to come.
• Outstanding performance led by Entrepreneurial culture.
• Product quality through Emotional Pharmacopoeia. • Management capability, Efficient processes and Technology. • Youth, hard work and discipline.
Achieved in a manner of fairness, honesty and corporate responsibility.
Facilities & Technologies
We have five manufacturing facilities spread over a 78-acre campus located in Ahmedabad, India.
Our manufacturing facilities are ISO 9001-2000 and WHO GMP certified. In addition, the Company has won several Indian Drug Manufacturers' Association Quality Excellence Awards as well as Frost & Sullivan India Manufacturing Excellence Award, in recognition of the quality of our manufacturing & supply chain practices.
Besides manufacturing our own products which we sell under our own brands, we use our facilities to manufacture products which are sold to Indian and international companies who market such products under their own brands.
Manufacturing Capabilities
The company has capabilities in bringing laboratory batches to full production scale successfully, through its process engineering competence.
•Blow-Fill-Seal (BFS) technology for plastic bottles
• Plastic bottles
Quality Policy We shall strive to fulfill our objective of saving lives worldwide by dedicating ourselves to manufacturing and marketing international Quality products and achieve excellence in all aspects of work. We shall achieve this by building Quality into our products and services through Research, Technology, Systems, Policies and Practices, People and benchmarking against internationally accepted norms of excellence.
It will be our endeavour to bring delight to our internal and external customers through excellence and continuous improvement.Emotional Pharmacopoeia
A total commitment to quality, coupled with international exposure to technology, aids us in our efforts to help save human lives worldwide. At the
core of our Quality Philosophy is the commitment to achieve a level of perfection that matches the highest international pharmacopoeial standards.
Our final test for Quality is a very simple question that we ask ourselves without fail.
“Would we use it to treat our dearest ones?”
If the answer is an unhesitant “Yes,” The product has passed our final quality test.
We call this “Emotional Pharmacopoeia.” The company's focus on quality begins with the use of world class Clean Rooms to house the central laboratory facilities.
The state-of-the-art laboratory set up is equipped with facilities for chemical and instrumental analysis. Capable of undertaking the most comprehensive tests, the laboratory has equipment sourced from
This facility is validated as per international regulatory authorities' expectations. A full-fledged validation team worked continuously at the time of inception, to achieve the levels of validation on a regular basis. To build quality through every step of production there is a separate team for in-process quality assurance (QA) and finished products' testing (QC) at the end. Separate managers head
internationally renowned suppliers. both these functions.
Claris' sterile manufacturing facility has won the prestigious Indian Drug Manufacturers' Association (IDMA) Quality Excellence Award for 4 years.
Regulatory Capabilities
The company's regulatory team has a sound and complete understanding of international regulatory requirements, and has several key regulatory
approvals to its credit.
The team has been able to obtain over 1,100 product registrations worldwide so far. Marketing Authorization Applications have been filed in
regulated markets including the USA, European Union countries, Australia, New Zealand etc.
The team develops formulations for generic products in accordance with the most stringent regulatory requirements. Formulation studies, method
development and validation, study on container closure systems and stability studies are conducted in line with international guidelines.
The clinical trial team's capabilities include preparation of protocols in line with ICH guidelines, identification, education and selection of study centers, regulatory procedures and approvals from government bodies, monitoring
and recording data during study, as well as final report writing and statistical analysis of data. The team carries out both clinical trials as well as bio-
equivalence studies.
The strength of the regulatory team lies in trained and committed manpower for different aspects including Regulated and Semi-
Regulated markets
Blood product
Claris' blood product range like Norglobin IVIG (human immunoglobulin) caters to the needs of patients with immuno deficiency, which reduces their capacity to fight diseases. A number of new products are in the pipeline in
this category.
List of Products
Normal Immunoglobulin
Anti- infactives
Claris has a wide range of broad-spectrum anti-infectives in its product
basket. The quinolone range has Ciprox (ciprofloxacin IV), Curadex (ofloxacin IV), as well as the more advanced Levox (levofloxacin IV), and
Victobax (gatifloxacin IV). Anzolid (linezolid IV) - is a novel class of antibacterial drug, and one of the most powerful products to be used
exclusively in ICUs, and life threatening infections like septicemia. Metris (metronidazole IV) is an anaerobic antibacterial belonging to the
nitromidazole class of anti-infectives. The cephalosporins range has higher generation molecules like Cefovin
(cefprirome IV) and Ceftid (ceftazidime IV), and also includes Cefo (cefotaxime IV) and Ceftrion (ceftriaxone IV). Some more III & IV generation
cephalosporins are in the development pipeline.List of Products
Quinolone Ciprofloxacin IV Ofloxacin IV Levofloxacin IV
The company's commitment to research is manifested through the R&D team. The team's focus is in
the area of development of innovative New Drug Delivery Systems (NDDS) for the management of critical illnesses. R&D team has pioneered a number of technologies in the last few years.
• The company used R&D team's expertise in the area of Parenteral Fat Emulsions (Lipid Drug Delivery Systems) to manufacture Propofol.
• R&D team has developed expertise in Liposomal Drug Delivery Systems. There are several drugs in the pipeline, which have reached a threshold for the next stage in development.
• Development of products like TNA/TNA-Peri/PNA (triple /double chamber nutrition system), Glutammune (l-glutamine), TetraHES (tetrastarch), Sufentil (sufentanil citrate Inj.) are significant breakthroughs for R&D team.
• A proprietary multi-layer film has been developed for bag manufacturing.
• Specific bulk drugs development (API) like Hydroxyethyl starch, Iron sucrose, makes Claris one of the few manufacturers of such APIs in the world.
R&D team of qualified scientists with background in pharmaceutical sciences and allied areas, networks with the global scientific community including companies, universities and scientists with similar interest areas.
Dr. Pravin P. Shah, Non-Executive Chairman and Independent Director
Dr. Pravin P. Shah is the Non-Executive Chairman of the Board and is an Independent Director of the Company. He was appointed as a Director on April 27, 1999. He holds a bachelor’s degree in commerce
and doctorate in finance from Mumbai university and is also a qualified Chartered Accountant and costs and works accountant. He is a partner in Pravin P Shah & Company, a chartered accountancy firm and sole proprietor of Pravin P Shah and Associates, Chartered Accountants. He has authored several books on costing, management strategies and taxations. He has over 40 years of experience in the areas of financial consultancy, valuations, taxation, property matters, accounting and auditing, corporate laws and laws relating to foreign exchange. He has also taught many courses including on Business Planning in the U.S.A. and on Tax Planning at the Jamanalal Bajaj Institute of Management at Mumbai.
He has also been serving as an independent director on the board of eminent public limited companies including JM Financial Ltd., Adani Enterprises Ltd., Jai Corp Ltd., Bombay Rayon Fashions Ltd., Milestone Capital Ltd., Raheja Universal Ltd. and Benchmark Trustee Company Private Limited. He is also acting as a member and/ or chairman of various committees of companies where he is a director. As at 31st December, 2010, he is holding Nil shares of the Company.
Mr. Arjun S. Handa, Promoter, Managing Director and CEO
Mr. Arjun S. Handa is a Post Graduate in Management from Northeastern University, Boston, USA and holds a Bachelor of Commerce degree from Gujarat University, Ahmedabad. He was appointed as Director
of our Company on February 19, 2001 was Chief Operating Officer of our Company from January 1, 2008 to September 26, 2008. He has been the Managing Director & CEO of our Company since September 26, 2008. He is responsible for our Company’s operations across various functions including sales and marketing, manufacturing and supply chain management, project execution and product development, in addition to being involved in strategy development.
Mr. Aditya S. Handa, Non-Executive and Non-Independent Director
Mr. Aditya S. Handa holds a Bachelor of Commerce degree from the Gujarat University, Ahmedabad. He was appointed as a Director of the Company on June 13, 2006 and has served as CFO of the Company from January 1, 2008 to March 31, 2009, which was his first employment.
Mr. Chandrasingh Purohit, Executive Director (President – Finance)
Mr. Chandrasingh Purohit holds a Master of Commerce degree from Maharaj Shivajirao University, Vadodara. Mr. Chandrasingh Purohit was appointed as an Executive Director of our Company with effect from July 3, 2009. He was previously employed with our Company since April 1, 1999 under various designations including Head – International Operations and Vice-President – Finance. Mr. Chandrasingh Purohit has around 13 years of experience in the pharmaceutical industry. Prior to joining our Company, he was an employee of CHL. He has been instrumental in setting up the Company's sales and marketing network across key international markets.
Top
Mr. Amish Vyas, Executive Director (President – International Business & Strategy)
Mr. Amish Vyas, holds a Bachelor of Electronics and Communication degree from Gujarat University, Ahmedabad and holds a Master of Business Administration degree from Gujarat University, Ahmedabad. He has been with our Company since February 1, 2003 and has about 15 years of experience in the pharmaceutical industry. He has been responsible for spearheading our Company’s foray in the regulated markets such as North America, Europe, Australia, New Zealand and others. Since 2009 he has taken over the additional responsibility for the sales in Latin America. Over and above that he has been actively involved in corporate level strategic assignments. Prior to joining our Company, he was an employee of CHL.
Mr. Chetan S. Majmudar, Executive Director (President – Technology & CQA)
Mr. Chetan S. Majmudar oversees the technical aspects of our Company. He holds a Bachelor of Science degree from Saurashtra University, Rajkot. He joined our Company on April 1, 1999 and has around 34 years of experience in the pharmaceutical industry. He has been involved in obtaining various regulatory approvals from authorities such as USFDA, MHRA & TGA for our Clarion manufacturing facilities. Prior to joining our Company, he was an employee of CHL. He is responsible for development, manufacturing and quality of products.
Mr. Nikhil Mohta is a Non-Executive Director of the Company and holds a post graduate diploma in management from Indian Institute of Management, Ahmedabad. He has nearly 10 years of experience. Earlier, Mr. Nikhil was the Nominee Director on the Board of the Company representing First Carlyle Ventures III. Prior to joining Carlyle, Mr. Mohta was an associate at McKinsey & Company, India. Mr. Mohta has worked on consulting engagements with senior managements of leading companies in various industries such as chemicals, oil and gas, banking and telecommunications industries. He worked across multiple functions such as strategy, operations, business building and organisation. As on 31st December 2010, he is holding 1421 Equity Shares of the Company.
Mr. T. V. Ananthanarayanan, Independent Director
Mr. T. V. Ananthanarayanan is the Non-Executive and Independent Director of the Company and was appointed as Director of the Company on January 28, 2008. He holds a Master of Science degree in Biomedical engineering from the Indian Institute of Technology, Chennai, and is a graduate in mechanical engineering from the Indian Institute of Technology, Chennai. Mr. T. V. Ananthanarayanan is a Trained Behavioural Scientist, Yoga Teacher and an Engineer; Founder of the consulting firm "FLAME TAO Knoware"—a team of functional experts all of whom are Behavioural Scientists focusing on Organizational Transformation, Alignment and Optimization; and Chairperson Sumedhas Academy for Human Context—a non profit organization focusing on
developing behavioral scientists. His consulting experience spans three decades: organization turnarounds, leadership coaching, culture transformations. His clients include TCS, Infosys, Laxmi Machine Works, ITC and EPCOS. He pioneered the use of Yoga and Theatre in process work. He has published many papers and two books: Learning through Yoga and The Totally Aligned Organization. His goal is to develop a unique approach to management at a personal level and at an organizational level based on the three streams of his expertise namely, Lean Management, Yoga and Behavioural Sciences. As on 31st December 2010, he is holding nil shares of the Company.
Mr. Surrinder Lal Kapur, Independent Director
Mr. Kapur holds a post graduate degree in Mathematics and is a graduate in Law from Punjab University, and has completed his training in public administration from the National Academy of Administration, Mussoorie. He has had practical experience in banking and promotion of industrial investments. He works as an honorary adviser to the President, PHDCCI (PHD Chamber of Commerce & Industry, a regional chamber of commerce covering 11 Northern States and Union Territories of India). He served in the Indian Administrative Service for about 35 years. He retired from Public Service as Chairman of the Board for Industrial and Financial Reconstruction. He is practising as an Advocate and is proprietor of a law firm known as “S.L. Kapur & Associates”. He has floated a charitable trust known as Poverty Alleviation through Generation of Employment Trust to provide employment opportunities to youth belonging to
backward classes and rural areas.
The Registrar & Transfer Agent – Address and Contact Details
We are constantly looking for partners with whom we could do business and grow together, we would be delighted to explore possibilities of working together with you for any opportunity including the following: Distribution/marketing partners In Licensing
Claris is in search for the right kind of distributor/marketing partner for
various countries across the world.
Claris has its presence in 76 countries across the world with an established team and distribution network. Claris
is well placed to maximize its products' sales potential in numerous markets across the world. Claris offers companies an opportunity to multiply its sales in a short time by leveraging
Claris' worldwide sales and distribution network.
Contract Manufacturing & Development
Out Licensing & Development
Claris' manufacturing facility has been approved by leading regulatory agencies in the world, giving us the capability to formulate, develop and manufacture existing products for various markets through Contract manufacturing & related services. The company has capabilities to manufacture new products right from API sourcing till dossier development for regulated and semi regulated markets.
Claris seeks various for numerous products developed/registered/ready to be registered in countries across the world. Claris is interested in working with potential partners across the world to market these products in respective countries. The company is developing a range of products, currently at different stages of development.
Leveraging Domestic Sales Network
Claris has a well established Sales and Distribution network in India and is open to leveraging its strength with companies which have a product baskets and would like to use our network of Distributors,
Marketing Partners, C&F Agents, Stockiest, etc.
For discussing any opportunity that you may feel can mutually benefit us please contact:
Name: Milina Bose Vice President - Global Marketing and Business Development Phone: (Ext - 15003)
